Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans
Cecilia S. Lindestam Arlehamn, Denise M. McKinney, Chelsea Carpenter, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 7, pp. e1005760-e1005760
Open Access | Times Cited: 133

Showing 26-50 of 133 citing articles:

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
Joshua S. Woodworth, Helena Strand Clemmensen, Hannah Battey, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients
Rashmi Tippalagama, Akul Singhania, Paige Dubelko, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 2, pp. 523-533
Open Access | Times Cited: 56
Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection
Sudhasini Panda, Jeffrey Morgan, Catherine Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Specific immune response to M. tuberculosis and ability to in vitro control mycobacterial replication are not impaired in subjects with immune-mediated inflammatory disease and tuberculosis infection
Chiara Farroni, Anna Maria Gerarda Altera, A. Salmi, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Rebooting Human Immunology
Mark M. Davis, Petter Brodin
Annual Review of Immunology (2018) Vol. 36, Iss. 1, pp. 843-864
Open Access | Times Cited: 75
Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas
Alba Grifoni, Michael A. Angelo, Benjamín López, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 74
Select sequencing of clonally expanded CD8+T cells reveals limits to clonal expansion
Huang Huang, Michael J. Sikora, Saiful Islam, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 18, pp. 8995-9001
Open Access | Times Cited: 74
Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses
Ricardo da Silva Antunes, Sinu Paul, John Sidney, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0169086-e0169086
Open Access | Times Cited: 71
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Tracey A. Day, Adam Penn‐Nicholson, Angelique Kany Kany Luabeya, et al.
The Lancet Respiratory Medicine (2020) Vol. 9, Iss. 4, pp. 373-386
Closed Access | Times Cited: 66
Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression
Michelle A. Sallin, Keith D. Kauffman, Catherine Riou, et al.
Nature Microbiology (2018) Vol. 3, Iss. 11, pp. 1198-1205
Closed Access | Times Cited: 65
Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination
Mariateresa Coppola, Tom H. M. Ottenhoff
Seminars in Immunology (2018) Vol. 39, pp. 88-101
Open Access | Times Cited: 61
Limited recognition of Mycobacterium tuberculosis-infected macrophages by polyclonal CD4 and CD8 T cells from the lungs of infected mice
Yash R. Patankar, Rujapak Sutiwisesak, Shayla Boyce, et al.
Mucosal Immunology (2019) Vol. 13, Iss. 1, pp. 140-148
Open Access | Times Cited: 59
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Alison Tarke, John Sidney, Conner K. Kidd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 52
Epitope prediction and identification- adaptive T cell responses in humans
John Sidney, Bjoern Peters, Alessandro Sette
Seminars in Immunology (2020) Vol. 50, pp. 101418-101418
Open Access | Times Cited: 50
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG
Carlos Martı́n, Dessislava Marinova, Nacho Aguiló, et al.
Vaccine (2021) Vol. 39, Iss. 50, pp. 7277-7285
Open Access | Times Cited: 48
Classical CD4 T cells as the cornerstone of antimycobacterial immunity
Jeffrey Morgan, Kaylin Muskat, Rashmi Tippalagama, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 10-29
Open Access | Times Cited: 47
Host genetic background is a barrier to broadly effective vaccine–mediated protection against tuberculosis
Rocky Lai, Diana Gong, Travis Williams, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 20
IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques
Christine E Nelson, Christine E Nelson, Christine E Nelson, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012339-e1012339
Open Access | Times Cited: 6
T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
Munyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, et al.
European Respiratory Journal (2018) Vol. 51, Iss. 3, pp. 1800153-1800153
Open Access | Times Cited: 57
Protein nanovaccine confers robust immunity against Toxoplasma
Kamal El Bissati, Ying Zhou, Sara M. Paulillo, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 55
Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis
Elsa Du Bruyn, Sheena Ruzive, Cecilia S. Lindestam Arlehamn, et al.
Mucosal Immunology (2020) Vol. 14, Iss. 2, pp. 491-499
Open Access | Times Cited: 48
Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
Catherine Riou, Elsa Du Bruyn, Sheena Ruzive, et al.
Clinical & Translational Immunology (2020) Vol. 9, Iss. 9
Open Access | Times Cited: 44
The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses
Ricardo da Silva Antunes, Daniela Weiskopf, John Sidney, et al.
Current Protocols (2023) Vol. 3, Iss. 11
Open Access | Times Cited: 15
A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG
Karin Dijkman, Thomas Lindenstrøm, Ida Rosenkrands, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 13
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen
Paul Ogongo, Anthony Tran, Florence Marzan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Scroll to top